Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases
β Scribed by Andersson, L. ;Eriksson, O. ;Hedlund, P.-O. ;Kjellman, H. ;Lindqvist, B.
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 368 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions. Since it is eliminated mainly in the urine, the drug accumulates in patients with uraemia. The excretion of tranexamic acid in patients with renal failure has been investigated and dosage recommendations are given for tranexamic acid therapy in cases of renal failure.
π SIMILAR VOLUMES
## Abstract **Background**: Around 16% of all patients who present with atheromatous renovascular disease (ARVD) in the United States undergo revascularization. Historically, patients with advanced chronic kidney disease (CKD) have been considered least likely to show improvement in renal functiona
## Abstract The development of standardized and reproducible clinical pathways is an important precondition for quality assurance in medicine, especially if a new method has not yet been ultimately validated. Sentinel lymph node biopsy (SLNB) is a widely accepted new surgical procedure in the treat